Showing results (841-850 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|March 3, 2025
Light-based technologies in immunotherapy: advances, mechanisms and applicationsDavide Frumento, Ștefan ŢăluImmunotherapy|February 28, 2025
Pharmacokinetics and safety of CT‑P39 via auto-injector are comparable to reference omalizumab via pre-filled syringeTomoko Hasunuma, Clive Grattan, Takashi Eto, et al.Immunotherapy|January 20, 2025
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinationsMatilde Corianò, Alessandro Lazzarin, Michele Maffezzoli, et al.Immunotherapy|January 18, 2025
Disparities in utilization of novel cancer therapies in advanced stage III and IV melanoma and variance in outcomesMohammad S Ali, Jae Ahn, N Joseph Espat, et al.Immunotherapy|November 26, 2024
Avoided recurrences and costs with adjuvant atezolizumab for patients with early non-small cell lung cancer in EuropeAlastair Greystoke, Nick Jovanoski, Pavel Napalkov, et al.Immunotherapy|October 9, 2024
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergensRashi Ramchandani, Rachel Lucyshyn, Sophia Linton, et al.Immunotherapy|September 4, 2024
Engineered T cells for Colorectal CancerNurul Ainaa Adilah Rus Bakarurraini, Ammar Akram Kamarudin, Rahman Jamal, et al.Immunotherapy|August 8, 2024
The development of anti-PD-1 antibody-induced spinal cord injury in bone marrow transplant C57BL/6 Rag1 mouse modelHuachun Chen, Zhouxiao Lu, Xiaowei Ni, et al.Immunotherapy|August 6, 2024
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapyFabiana Perrone, Federica Pecci, Michele Maffezzoli, et al.Immunotherapy|July 29, 2024
C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive reviewCarl J Danzig, Arshad M Khanani, Anat LoewensteinPageof 190